Denemek ALTIN - Özgür

Markets See Red as Indo-Pak Tensions Continue to Rise

Mint Chennai

|

May 10, 2025

The set up indicates continuation of the downside pressure, unless tensions abate

- Ram Sahgal

Benchmark indices closed in the red for the second straight session on Friday amid fears of India and Pakistan escalating tensions. While both Nifty and Sensex recovered from their intraday lows, anticipation of tensions over the weekend led foreign portfolio investors (FPIs) to press the sell button in both the cash and derivatives segment.

The setup by the end of the day indicates continuation of the downside pressure, unless tensions abate. Selling in heavyweights such as ICICI Bank, HDFC Bank and Reliance Industries dragged both Nifty and Sensex down by 1.1% each. Nifty closed down by 266 points at 24,008, slightly below its 200-day moving average of 24,044.25, a bearish sign. The Sensex, which settled 880 points lower at 79,454.47, managed to close slightly above its 200 DMA of 79,114, per Bloomberg data.

FPIs' changed stance in cash markets on Friday—they sold shares worth a provisional ₹3,798.71 crore—came after sixteen straight sessions of net buying ₹16,473 crore. FPIs also sold index and stock futures worth a net ₹4,346 crore amid escalating tensions, BSE and National Stock Exchange (NSE) data showed. The sale of index futures on Friday once again made them cumulatively net short after two days.

Mint Chennai'den DAHA FAZLA HİKAYE

Mint Chennai

Mint Chennai

Lenskart wants artificial intelligence to test your eyes

It expects AI-enabled eye testing to become the default foundational layer of eyecare delivery

time to read

3 mins

January 13, 2026

Mint Chennai

Mint Chennai

More companies to take a hit as labour codes debut

Reworked gratuity and leave encashments spell additional expenses for India Inc

time to read

2 mins

January 13, 2026

Mint Chennai

HC lifts ban on Zydus cancer biosimilar till patent expiry

In a relief for Zydus Lifesciences, a division bench of the Delhi High Court on Monday allowed the drugmaker to sell and market its biosimilar of the anticancer drug nivolumab in India, citing public interest.

time to read

2 mins

January 13, 2026

Mint Chennai

Trump’s investigation of Powell is also a warning to the next Fed chair

The criminal investigation into Federal Reserve Chair Jerome Powell isn’t ultimately about the Fed’s headquarters, or Powell, or even interest rates.

time to read

3 mins

January 13, 2026

Mint Chennai

Mint Chennai

States flag Almont-Kid syrup as tests find contaminants

Syrup found ‘Not of Standard Quality’ with contaminants like toxic ethylene glycol

time to read

1 mins

January 13, 2026

Mint Chennai

Mint Chennai

India at 100: Our choices today will define the next two decades

India's 2047 ambition is not guaranteed but achievable if we address all the potential pitfalls along our development path

time to read

4 mins

January 13, 2026

Mint Chennai

Now, inheritance works without probate—but why it still matters

Heirs can now act on a valid will without court cases, easing delays and unlocking assets in undisputed cases

time to read

6 mins

January 13, 2026

Mint Chennai

Why VCs have a new deep-tech playbook

where fundraising starts to drag,\" said Chand.

time to read

1 min

January 13, 2026

Mint Chennai

TCS, HCLTech deliver Q3 revenue surprise

clearer.

time to read

2 mins

January 13, 2026

Mint Chennai

Mint Chennai

US productivity is rising and it risks warping monetary policy

America's neutral rate ought to be going up but will the Fed listen?

time to read

3 mins

January 13, 2026

Listen

Translate

Share

-
+

Change font size